Compositions and methods for treating the eye

US11357805B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11357805-B2
Application numberUS-202017029236-A
CountryUS
Kind codeB2
Filing dateSep 23, 2020
Priority dateJul 27, 2018
Publication dateJun 14, 2022
Grant dateJun 14, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to compositions comprising one or more compounds and/or extracts which induce, promote and/or improve production/release/delivery/excretion of mucin from and/or in the cornea, and methods of using the compositions to treat the eye.

First claim

Opening claim text (preview).

What is claimed is: 1. A composition for treating the eye comprising: i) one or more extracts of the genus Pichia ; and ii) an ophthalmologically acceptable carrier comprising one or more excipients selected from demulcents, tonicity agents, preservatives, chelating agents and buffering agents wherein the composition is a sterile composition. 2. The composition according to claim 1 , wherein the species of the genus of Pichia is selected from Pichia anomala, Pichia guilliermondii, Pichia norvegensis, Pichia ohmeri and mixtures thereof. 3. The composition according to claim 2 , wherein the species of the genus of Pichia is Pichia anomala. 4. The composition of claim 1 , where in the one or more extracts of the genus Pichia are present at a concentration of from about 0.001% to about 95% by weight of the total composition. 5. The composition of claim 1 , where in the one or more extracts of the genus Pichia are present at a concentration of from about 0.005% to about 95% by weight of the total composition. 6. The composition of claim 1 , where in the one or more extracts of the genus Pichia are present at a concentration of from about 0.01% to about 90% by weight of the total composition. 7. The composition according to claim 1 , comprising a permeation enhancer. 8. The composition of claim 7 wherein the permeation enhancer is present at a concentration of from about 0.01% to about 20% (w/v) of the total composition. 9. The composition of claim 8 wherein the permeation enhancer is present at a concentration of from about 0.1% to 10% (w/v) of the total composition. 10. The composition of claim 9 wherein the permeation enhancer is present at a concentration of from about 0.25% to 5% (w/v) of the total composition. 11. The composition of claim 7 wherein the permeation enhancer is selected from polyoxyethylene, polyoxyethylene ethers of fatty acids, sorbitan monooleate, sorbitan monolaurate, polyoxyethylene monolaurate, polyoxyethylene sorbitan monolaurate, fusidic acid and derivatives thereof, ethylenediaminetetraacetic acetate (EDTA), disodium EDTA, cholic acid, deoxycholic acid, glycocholic acid, glycodeoxycholic acid, taurocholic acid, taurodeoxycholic acid, sodium cholate, sodium glycocholate, glycocholate, sodium deoxycholate, sodium taurocholate, sodium glycodeoxycholate, sodium taurodeoxycholate, chenodeoxycholic acid, urosdeoxycholic acid, saponins, glycyrrhizic acid, ammonium glycyrrhizide, decamethonium, decamethonium bromide, and dodecyltrimethylammonium bromide or mixtures of any of the above. 12. The composition of claim 1 wherein the Pichia genus extract comprises oligosaccharides and polysaccharides having a weight average molecular weight of from about 180 to about 800,000 Daltons. 13. The composition of claim 1 wherein the Pichia genus extract comprises oligosaccharides and polysaccharides having an average degree of polymerization (DP) of from DP 1 to DP 4444.

Assignees

Inventors

Classifications

  • A61K9/0048Primary

    Eye, e.g. artificial tears · CPC title

  • Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin · CPC title

  • A61K36/064Primary

    Saccharomycetales, e.g. baker's yeast · CPC title

  • Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers · CPC title

  • Solutions {(composition of solutions A61K47/00)} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11357805B2 cover?
The present invention relates to compositions comprising one or more compounds and/or extracts which induce, promote and/or improve production/release/delivery/excretion of mucin from and/or in the cornea, and methods of using the compositions to treat the eye.
Who is the assignee on this patent?
Johnson & Johnson Surgical Vision Inc
What technology area does this patent fall under?
Primary CPC classification A61K9/0048. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 7 related publications on this page (citations in our corpus or others sharing the same primary CPC).